The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...
United Therapeutics is a Buy: strong core growth, a goal of $1B quarterly revenue by 2027, plus catalysts ralinepag & Tyvaso ...
Complex chemical processes are essential for making DNA." This long-held assumption in the field of biotechnology has been overturned by a Korean ...
Biotech is having a moment, and the numbers are hard to ignore. The SPDR S&P Biotech ETF (NYSEARCA:XBI) climbed 17.27% over ...
Investor's Business Daily on MSN
Why this biotech, up 12% since its breakout, yo-yoed on a key FDA development
Pharvaris stock jumped early Monday, but closed down, after the FDA agreed to review the company's treatment for a serious ...
As climate change brings longer droughts, more frequent heat waves and increasingly unpredictable growing conditions to ...
Transparency and intellectual property are crucial when it concerns money being spent towards public interest.
Equity Insider News Commentary, The scramble to build a critical-minerals supply chain outside China has become one of the ...
A biotech startup and an aerospace startup said their moves to Colorado were based on lifestyle issues and the state’s ...
Unlike conventional Vitamin D3, which is typically sourced from sheep's wool lanolin, the Thane-based company's VITADEE Green ...
China and Hong Kong stocks rose on Monday as signs emerged that investor enthusiasm for artificial intelligence was ...
Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results